Westlake Chemical (WLK) Misses Q4 EPS by 15c

Westlake Chemical (NYSE: WLK) reported Q4 EPS of $0.84, $0.15 worse than the analyst estimate of $0.99. Revenue for the quarter came in at $986.8 million versus the consensus estimate of $1.03 billion.

For earnings history and earnings-related data on Westlake Chemical (WLK) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Dare Bioscience (DARE) Tops Q2 EPS by 11c
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94